Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 31, 2023 5.05% = 2.74% × 1.84
Dec 31, 2022 3.97% = 2.15% × 1.85
Sep 30, 2022 3.70% = 2.04% × 1.81
Jun 30, 2022 5.12% = 2.75% × 1.87
Mar 31, 2022 4.84% = 2.50% × 1.93
Dec 31, 2021 6.26% = 3.23% × 1.94
Sep 30, 2021 7.02% = 3.62% × 1.94
Jun 30, 2021 3.64% = 1.86% × 1.96
Mar 31, 2021 1.58% = 0.80% × 1.97
Dec 31, 2020 -0.54% = -0.27% × 2.01
Sep 30, 2020 23.80% = 12.01% × 1.98
Jun 30, 2020 25.53% = 12.93% × 1.97
Mar 31, 2020 31.06% = 14.24% × 2.18
Dec 31, 2019 33.87% = 15.38% × 2.20
Sep 30, 2019 11.24% = 4.07% × 2.76
Jun 30, 2019 14.81% = 5.74% × 2.58
Mar 31, 2019 19.46% = 7.55% × 2.58
Dec 31, 2018 19.15% = 7.96% × 2.41
Sep 30, 2018 — = — × 2.46
Jun 30, 2018 — = — × 2.53
Mar 31, 2018 — = — × 2.73

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q1 2023 is the increase in profitability measured by return on assets ratio (ROA).

Three-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 31, 2023 5.05% = 6.91% × 0.40 × 1.84
Dec 31, 2022 3.97% = 5.50% × 0.39 × 1.85
Sep 30, 2022 3.70% = 5.20% × 0.39 × 1.81
Jun 30, 2022 5.12% = 7.17% × 0.38 × 1.87
Mar 31, 2022 4.84% = 6.66% × 0.38 × 1.93
Dec 31, 2021 6.26% = 8.76% × 0.37 × 1.94
Sep 30, 2021 7.02% = 10.07% × 0.36 × 1.94
Jun 30, 2021 3.64% = 5.19% × 0.36 × 1.96
Mar 31, 2021 1.58% = 2.45% × 0.33 × 1.97
Dec 31, 2020 -0.54% = -0.83% × 0.32 × 2.01
Sep 30, 2020 23.80% = 36.65% × 0.33 × 1.98
Jun 30, 2020 25.53% = 39.24% × 0.33 × 1.97
Mar 31, 2020 31.06% = 39.75% × 0.36 × 2.18
Dec 31, 2019 33.87% = 43.78% × 0.35 × 2.20
Sep 30, 2019 11.24% = 10.49% × 0.39 × 2.76
Jun 30, 2019 14.81% = 13.85% × 0.41 × 2.58
Mar 31, 2019 19.46% = 18.08% × 0.42 × 2.58
Dec 31, 2018 19.15% = 17.01% × 0.47 × 2.41
Sep 30, 2018 — = — × — × 2.46
Jun 30, 2018 — = — × — × 2.53
Mar 31, 2018 — = — × — × 2.73

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q1 2023 is the increase in profitability measured by net profit margin ratio.

Five-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 31, 2023 5.05% = 0.63 × 0.85 × 12.92% × 0.40 × 1.84
Dec 31, 2022 3.97% = 0.61 × 0.71 × 12.70% × 0.39 × 1.85
Sep 30, 2022 3.70% = 0.75 × 0.64 × 10.81% × 0.39 × 1.81
Jun 30, 2022 5.12% = 0.80 × 0.68 × 13.13% × 0.38 × 1.87
Mar 31, 2022 4.84% = 0.89 × 0.63 × 11.88% × 0.38 × 1.93
Dec 31, 2021 6.26% = 0.97 × 0.76 × 11.92% × 0.37 × 1.94
Sep 30, 2021 7.02% = 0.91 × 0.78 × 14.07% × 0.36 × 1.94
Jun 30, 2021 3.64% = 1.05 × 0.61 × 8.07% × 0.36 × 1.96
Mar 31, 2021 1.58% = 1.11 × 0.39 × 5.72% × 0.33 × 1.97
Dec 31, 2020 -0.54% = — × -0.28 × 2.84% × 0.32 × 2.01
Sep 30, 2020 23.80% = — × -7.40 × 0.52% × 0.33 × 1.98
Jun 30, 2020 25.53% = — × -0.19 × 3.74% × 0.33 × 1.97
Mar 31, 2020 31.06% = 17.01 × 0.36 × 6.53% × 0.36 × 2.18
Dec 31, 2019 33.87% = 6.84 × 0.59 × 10.81% × 0.35 × 2.20
Sep 30, 2019 11.24% = 1.10 × 0.73 × 12.96% × 0.39 × 2.76
Jun 30, 2019 14.81% = 1.03 × 0.81 × 16.62% × 0.41 × 2.58
Mar 31, 2019 19.46% = 1.15 × 0.84 × 18.57% × 0.42 × 2.58
Dec 31, 2018 19.15% = 1.18 × 0.86 × 16.93% × 0.47 × 2.41
Sep 30, 2018 — = — × — × — × — × 2.46
Jun 30, 2018 — = — × — × — × — × 2.53
Mar 31, 2018 — = — × — × — × — × 2.73

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q1 2023 is the increase in effect of interest expense measured by interest burden ratio.

Two-Component Disaggregation of ROA

Boston Scientific Corp., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 31, 2023 2.74% = 6.91% × 0.40
Dec 31, 2022 2.15% = 5.50% × 0.39
Sep 30, 2022 2.04% = 5.20% × 0.39
Jun 30, 2022 2.75% = 7.17% × 0.38
Mar 31, 2022 2.50% = 6.66% × 0.38
Dec 31, 2021 3.23% = 8.76% × 0.37
Sep 30, 2021 3.62% = 10.07% × 0.36
Jun 30, 2021 1.86% = 5.19% × 0.36
Mar 31, 2021 0.80% = 2.45% × 0.33
Dec 31, 2020 -0.27% = -0.83% × 0.32
Sep 30, 2020 12.01% = 36.65% × 0.33
Jun 30, 2020 12.93% = 39.24% × 0.33
Mar 31, 2020 14.24% = 39.75% × 0.36
Dec 31, 2019 15.38% = 43.78% × 0.35
Sep 30, 2019 4.07% = 10.49% × 0.39
Jun 30, 2019 5.74% = 13.85% × 0.41
Mar 31, 2019 7.55% = 18.08% × 0.42
Dec 31, 2018 7.96% = 17.01% × 0.47
Sep 30, 2018 — = — × —
Jun 30, 2018 — = — × —
Mar 31, 2018 — = — × —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

The primary reason for the increase in return on assets ratio (ROA) over Q1 2023 is the increase in profitability measured by net profit margin ratio.

Four-Component Disaggregation of ROA

Boston Scientific Corp., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 31, 2023 2.74% = 0.63 × 0.85 × 12.92% × 0.40
Dec 31, 2022 2.15% = 0.61 × 0.71 × 12.70% × 0.39
Sep 30, 2022 2.04% = 0.75 × 0.64 × 10.81% × 0.39
Jun 30, 2022 2.75% = 0.80 × 0.68 × 13.13% × 0.38
Mar 31, 2022 2.50% = 0.89 × 0.63 × 11.88% × 0.38
Dec 31, 2021 3.23% = 0.97 × 0.76 × 11.92% × 0.37
Sep 30, 2021 3.62% = 0.91 × 0.78 × 14.07% × 0.36
Jun 30, 2021 1.86% = 1.05 × 0.61 × 8.07% × 0.36
Mar 31, 2021 0.80% = 1.11 × 0.39 × 5.72% × 0.33
Dec 31, 2020 -0.27% = — × -0.28 × 2.84% × 0.32
Sep 30, 2020 12.01% = — × -7.40 × 0.52% × 0.33
Jun 30, 2020 12.93% = — × -0.19 × 3.74% × 0.33
Mar 31, 2020 14.24% = 17.01 × 0.36 × 6.53% × 0.36
Dec 31, 2019 15.38% = 6.84 × 0.59 × 10.81% × 0.35
Sep 30, 2019 4.07% = 1.10 × 0.73 × 12.96% × 0.39
Jun 30, 2019 5.74% = 1.03 × 0.81 × 16.62% × 0.41
Mar 31, 2019 7.55% = 1.15 × 0.84 × 18.57% × 0.42
Dec 31, 2018 7.96% = 1.18 × 0.86 × 16.93% × 0.47
Sep 30, 2018 — = — × — × — × —
Jun 30, 2018 — = — × — × — × —
Mar 31, 2018 — = — × — × — × —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

The primary reason for the increase in return on assets ratio (ROA) over Q1 2023 is the increase in effect of interest expense measured by interest burden ratio.

Disaggregation of Net Profit Margin

Boston Scientific Corp., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 31, 2023 6.91% = 0.63 × 0.85 × 12.92%
Dec 31, 2022 5.50% = 0.61 × 0.71 × 12.70%
Sep 30, 2022 5.20% = 0.75 × 0.64 × 10.81%
Jun 30, 2022 7.17% = 0.80 × 0.68 × 13.13%
Mar 31, 2022 6.66% = 0.89 × 0.63 × 11.88%
Dec 31, 2021 8.76% = 0.97 × 0.76 × 11.92%
Sep 30, 2021 10.07% = 0.91 × 0.78 × 14.07%
Jun 30, 2021 5.19% = 1.05 × 0.61 × 8.07%
Mar 31, 2021 2.45% = 1.11 × 0.39 × 5.72%
Dec 31, 2020 -0.83% = — × -0.28 × 2.84%
Sep 30, 2020 36.65% = — × -7.40 × 0.52%
Jun 30, 2020 39.24% = — × -0.19 × 3.74%
Mar 31, 2020 39.75% = 17.01 × 0.36 × 6.53%
Dec 31, 2019 43.78% = 6.84 × 0.59 × 10.81%
Sep 30, 2019 10.49% = 1.10 × 0.73 × 12.96%
Jun 30, 2019 13.85% = 1.03 × 0.81 × 16.62%
Mar 31, 2019 18.08% = 1.15 × 0.84 × 18.57%
Dec 31, 2018 17.01% = 1.18 × 0.86 × 16.93%
Sep 30, 2018 — = — × — × —
Jun 30, 2018 — = — × — × —
Mar 31, 2018 — = — × — × —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

The primary reason for the increase in net profit margin ratio over Q1 2023 is the increase in effect of interest expense measured by interest burden ratio.